Gordon Findlay, an executive at Novo Nordisk, collapsed in the Oval Office on Thursday afternoon while President Trump announced a plan to lower the price of weight-loss medications, including Ozempic.
Findlay was promptly assisted, given medical care, and is expected to recover fully.
Gordon Findlay of Novo Nordisk collapsed in the Oval Office Thursday afternoon as President Trump announced a plan to reduce the price of weight-loss drugs, including Ozempic.
The incident occurred during a public announcement aimed at making weight-loss drugs more affordable.
Findlay was helped to his feet, given medical assistance and is expected to be fine.
Author's summary: Novo Nordisk executive Gordon Findlay fainted during a public event with President Trump on weight-loss drug pricing but received immediate care and is anticipated to recover without issues.